Targeting Epstein–Barr virus is a viable therapeutic strategy in multiple sclerosis: Commentary

Anna Karin Hedström

PMC · DOI:10.1177/13524585251409951·January 14, 2026

Targeting Epstein–Barr virus is a viable therapeutic strategy in multiple sclerosis: Commentary

Anna Karin Hedström

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Genes4

HLA-A ANO2 HEPACAM CRYAB

Proteins4

Species2

Homo sapiens(human · species)human gammaherpesvirus 4(Epstein Barr virus · no rank)

Diseases5

neuroaxonal injury EBV infection inflammatory ORCID iD MS

Figures1

Click any figure to enlarge with its caption.

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsMultiple Sclerosis Research Studies · Polyomavirus and related diseases · Herpesvirus Infections and Treatments